Rory B. Riggs - 20 Mar 2024 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
20 Mar 2024
Net transactions value
+$371,200
Form type
4
Filing time
22 Mar 2024, 16:12:23 UTC
Previous filing
22 Feb 2024
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise $371,200 +20,000 +25% $18.56 99,235 20 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Options Exercise $0 -20,000 -100% $0.000000* 0 20 Mar 2024 Common Stock 20,000 $18.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 20, 2024, the reporting person exercised options to purchase 20,000 shares of common stock that were expiring on March 21, 2024.
F2 On March 21, 2014, the reporting person was granted options to purchase 20,000 shares of common stock, vesting as to 50% of the shares on January 8, 2015 and as to the remainder of the shares on January 8, 2016.